Mission
NTMir's mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial (NTM) disease.
Strategic Plan
- Rapid Information Pilot Studies (RIPS)™, an innovative program that provides guidance about pressing research issues to secure large-scale research funding.
- Work with patient support groups who participate in the NTMir mission.
- Minimize lung damage associated with bronchiectasis and inflammation by supporting basic science, including the development of new medications, geared toward the treatment of NTM disease.
- Support multi-centered initiatives to benefit NTM patients, physicians and researchers.
- Engage patients and physicians in our goal to increase awareness of NTM among government agencies, industry, insurance companies, and laboratories.
- NTMir will provide leadership at the national level to meet all goals through inclusive collaborative efforts, education and advocacy.
Board Members
| Member | Affiliation | Location |
|---|---|---|
| Mary Allyn |
Director | Sarasota, FL |
| Amy Cherrnay |
Director |
Dallas, TX |
| Elizabeth Glaeser |
Director |
New York, NY |
| Michael Iseman, MD | National Jewish Health | Denver, CO |
|
Connie Kazanjian |
Director |
Miami, FL |
| Fern Leitman |
Patient, Co-Founder & Treasurer |
Miami, FL |
| Philip Leitman |
President & Co-Founder | Miami, FL |
Medical and Scientific Advisory Committee
| Member | Affiliation | Location |
|---|---|---|
| Timothy Aksamit, MD | Mayo Clinic | Rochester, MN |
| David Ashkin, MD | A.G. Holley Hospital | Lantana, FL |
| Kevin Fennelly, MD | University of Florida College of Medicine | Gainesville, FL |
| David Griffith, MD | University of Texas | Tyler, TX |
| Michael Iseman, MD | National Jewish Medical & Research Center |
Denver, CO |
| Richard Wallace, MD | University of Texas | Tyler, TX |
